A paper by A. Creak – Prospective Cohort of Referrals to a Cancer of Unknown Primary Clinic, including Direct Access from Primary Care – in Clinical Oncology: a Journal of the Royal College of Radiologists (2019 October 18) reporting on the Brighton CUP team is interesting. To quote from the summary: The Brighton cancer of unknown primary (CUP) clinic covers
Read more
Those who have followed the saga will recall our attempts over the years to get published the report of the 2016 external peer review of CUP services in England. It is still not available on an NHS website but we have been given permission by the Quality Surveillance Team to place it on our website – which we are pleased
Read more
We are particularly pleased to see the plan to roll-out Rapid Diagnostic Centres (RDCs) across the country following the 2018 trial. Cancer alliances are required to have at least one RDC site accepting patients NLT January 2020. The aim with RDCs is that ‘patients displaying symptoms of cancer can be assessed and diagnosed in as little as a day.’ Existing
Read more
The NHS Long Term Plan has now been launched which sets out the way forward for cancer services. Cancer and the NHS Long Term Plan In the consultation period, and in meetings with the team preparing the plan, we have pushed for genomic testing for CUP patients and it is pleasing to see in the attached ‘The offer of genomic testing
Read more
Prof Mark Caulfield has sent out this message: On the 5th December 2018 Genomics England announced that we reached our 100,000 genome milestone. The sequencing of 100,000 whole genomes marks an extraordinary UK achievement that is transforming the application of genomics in our NHS. Genomics England and NHS England are extremely grateful to the 85,000 participants, 1,500 NHS staff, over
Read more
Dr Kai Keen Shiu is quoted in Medscape Wednesday, October 29, 2018 in an article entitled ‘Cancer of Unknown Primary: Finding Mutations Alters Therapy’ by Liam Davenport which begins: ‘More than two thirds of patients with cancer of unknown primary (CUP) have mutations detectable on circulating tumor DNA (ct-DNA) testing, or so-called liquid biopsy. For these patients, ct-DNA testing could
Read more
This poster presented at ESMO this week summarises the CUPISCO trial ESMO 2018_CUPISCO poster
We have been battling for some years to get this report released. The review process was an invaluable exercise in raising standards for CUP patients in England and whilst each hospital trust will have received feedback there has been no way to look at the overall picture…..until now. Following a change of leadership at QST and with the help of
Read more
For many years CUP was covered within a sub group of the Upper GI Clinical Studies Group (CSG) of the National Cancer Research Institute. Recommendations for UK CUP research projects would be subject to peer review by the group prior to submission for funding . Towards the end of 2017 NCRI reviewed the positioning of CUP and it was removed
Read more
Our next international conference – CUP 2019 – will take place at the Royal College of Physicians on Friday 3 May. The conference chairman will be the world-leading authority on CUP: Dr Tony Greco. The focus of the day will be on CUP research and clinical management themes in the era of precision medicine. We are on the cusp of
Read more